-
FDA AdCom to question efficacy and safety concerns with Eli Lilly’s Alzheimer’s drug
07 Jun 2024 19:21 GMT
… a US Food and Drug Administration (FDA) Advisory … pharma giant as they look for approval of their Alzheimer’s drug … approved Alzheimer’s drugs, including Eisai and Biogen’s … marketing risk strategies including pharmacovigilance, with Lilly being required …
-
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
07 Jun 2024 16:22 GMT
… They included data on existing drugs, experimental treatments, AI tools … either Lenvima from Merck and Eisai or Nexavar from Bayer) … in combination with a drug called lazertinib. The study … The approved form of the drug is administered via intravenous …
-
Here’s how much Big Pharma pays physicians to endorse drugs on social media
07 Jun 2024 15:25 GMT
… Twitter, received payments from pharma companies, according to a … drugmakers was around $27,400.
However, most of Big Pharma’ … the study included Pfizer, GSK, Eisai, AstraZeneca, Novartis, Exelixis and … Care Act which required pharma companies to report their …
-
Eli Lilly tipped to leapfrog Eisai, Biogen and take control of $13B Alzheimer's market
07 Jun 2024 11:49 GMT
… about the drug’s growth trajectory. In May, Eisai tipped sales … can stop receiving the drug once amyloid levels reach … well below the expectations of Eisai, which has predicted Leqembi … population.
While the analysts expect Eisai, Biogen and Lilly to …
-
Delhi Police bust fake cancer drugs racket, Syrian national among 4 arrested
07 Jun 2024 11:28 GMT
… of counterfeit cancer drugs worth Rs 4 crore … medicines, including life-saving drugs. These include OPDIVO (BMS … (Novo Nordisk), and Lenvima (Eisai).
Syrian acted as carrier, … drugs), 275 (sale of adulterated drugs), 276 (sale of drug as a different drug …
-
No major concerns raised by USFDA staff on Eli Lilly Alzheimer's drug Donanemab
07 Jun 2024 11:25 GMT
… expect donanemab will be approved.
Drugs like donanemab and Leqembi, which … between the groups.
In Eisai and Biogen's late … Stifel analyst Paul Matteis.
Unlike Eisai and Biogen's trial … will benefit from the drug.
Participants in the donanemab trial …
-
FDA analysis raises no major concerns about Eli Lilly Alzheimer's drug
07 Jun 2024 02:04 GMT
… experimental Alzheimer's drug donanemab released on Thursday revealed … disease.
The drug is a potential rival to Eisai and Biogen… donanemab will be approved.
Drugs like donanemab and Leqembi, which … will benefit from the drug.
Participants in the donanemab …
-
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
06 Jun 2024 21:30 GMT
… three undervalued pharma stocks ones to buy
Pharma stocks have … Let’s say Eisai’s profits from the drug in 2029 come … pharma stocks to buy.
But Novo Nordisk has several blockbuster drugs … while the website gives the pharma an Accumulation/Distribution …
-
In review of Lilly Alzheimer’s drug, FDA staff focus on safety, patient selection
06 Jun 2024 21:09 GMT
… experimental Alzheimer’s disease drug donanemab is widely effective … controversy and few sales. Eisai, along with Biogen, more … and Central Nervous System Drugs Advisory Committee convene Monday, … reviews of Alzheimer’s drugs, particularly since the controversy …
-
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
06 Jun 2024 16:33 GMT
… experimental Alzheimer's drug donanemab released on Thursday revealed … disease.
The drug is a potential rival to Eisai and Biogen… donanemab will be approved.
Drugs like donanemab and Leqembi, which … to approve the Lilly drug.
(Reporting by Bhanvi Satija …